FMP
LakeShore Biopharma Co., Ltd.
LSBPW
NASDAQ
LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
0.0357 USD
0 (0%)
LSBPW Financial Statements
Year
2024
2023
2022
2021
Current Assets
903.17M
1.04B
1.03M
733.2M
Cash & Short Term Investments
246.35M
370.11M
885.2k
390.46M
Cash And Cash Equivalents
246.35M
370.11M
885.2k
390.46M
Short Term Investments
0
0
0
0
Net Receivables
447.15M
463.05M
308.56M
248.12M
Inventory
203.42M
185.38M
166.51M
81.44M
Other Current Assets
358.87k
576.81k
7.99M
74.51k
Non-Current Assets
609.86M
683.77M
200.01M
91.37k
Property, Plant & Equipment
480.62M
582.89M
565M
253.45M
Goodwill And Intangible Assets
71.25M
78.06M
80.72M
83.78M
Goodwill
0
0
0
0
Intangible Assets
71.25M
78.06M
80.72M
83.78M
Long Term Investments
0
0
200.01M
-345.21M
Tax Assets
23.63M
1.91M
3.04M
7.98M
Other Non-Current Assets
34.36M
20.92M
-648.76M
91.37k
Other Assets
0
0
0
-733.2M
Total Assets
1.51B
1.72B
201.03M
91.37k
-
-
-
-
Current Liabilities
802.23M
658.76M
142.63k
70.01k
Accounts Payable
67.77M
80.44M
30.81M
16.38M
Short Term Debt
318.54M
193.74M
111.73M
0
Tax Payables
3.01M
379.6k
1.17M
1.62M
Deferred Revenue
2.02M
2.3M
2.3M
2.12M
Other Current Liabilities
119.31M
108.8M
-381.24M
48.73M
Total Current Liabilities
802.23M
658.76M
142.63k
70.01k
Total Non-Current Liabilities
125.6M
332.54M
20.21M
1.33B
Long-Term Debt
98.98M
293.79M
253.93M
1.1M
Deferred Revenue
20.28M
23.61M
7M
30.88M
Deferred Taxes Liabilities
0
0
-264.53M
0
Other Non Current liabilities
4.55M
8.79M
-274.38M
1.29B
Total Liabilities
927.82M
991.3M
20.35M
70.01k
Other Liabilities
0
0
0
-1.33B
Stockholders Equity
585.21M
728.45M
180.68M
21.36k
Common Stock
26.11k
12.3k
575
575
Retained Earnings
-2.31B
-1.87B
-19.32M
-3.64k
Accumulated Other Comprehensive Income/Loss
-58.18M
-54.41M
83.09M
44.22M
Other Shareholders Equity
0
0
-490.56M
-1.29B
Total Liabilities and Stockholders Equity
1.51B
1.72B
201.03M
91.37k
All figures are in CNY.
